Somewhat Favorable Media Coverage Somewhat Unlikely to Impact UnitedHealth Group (UNH) Share Price

News articles about UnitedHealth Group (NYSE:UNH) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. UnitedHealth Group earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned media headlines about the healthcare conglomerate an impact score of 46.4325879292821 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the news stories that may have impacted Accern Sentiment’s rankings:

Several brokerages have issued reports on UNH. Jefferies Group reaffirmed a “buy” rating and set a $248.00 price target on shares of UnitedHealth Group in a report on Friday, December 1st. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Sanford C. Bernstein raised their price target on UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a report on Friday, December 1st. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $224.56.

UnitedHealth Group (NYSE:UNH) traded up $3.76 on Friday, hitting $223.91. The stock had a trading volume of 2,233,073 shares, compared to its average volume of 2,655,638. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $213,340.20, a P/E ratio of 22.93, a P/E/G ratio of 1.63 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter last year, the firm earned $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. sell-side analysts expect that UnitedHealth Group will post 9.99 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 33.26%.

In related news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the transaction, the director now owns 36,989 shares in the company, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. Insiders have sold 62,606 shares of company stock valued at $12,677,525 in the last three months. Insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply